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Purpose: The aim of this study was to investigate the factors associated with decreases in 
corneal endothelial cell density (ECD) resulting from cataract surgery in eyes with pseudoex-
foliation syndrome (PEX).
Methods: The clinical records of 78 eyes of 78 patients with PEX who had undergone cataract 
surgery were reviewed. ECD was measured preoperatively and at 3 months postoperatively 
with specular microscopy. Multiple regression analysis was used to assess the factors that were 
significantly related to the rate of ECD loss. Explanatory variables included age, preoperative 
ECD, pupil diameter, cataract grade, concomitance of glaucoma or diabetes mellitus, preopera-
tive anterior chamber depth, surgery time, total time and power of ultrasound, performance of 
intraoperative pupillary enlargement manipulation, and postoperative aqueous flare intensity 
at 1 week and 1 month.
Results: ECD before and after surgery was 2,464±337 cells/mm2 and 2,400±347 cells/mm2, 
respectively, with an ECD loss rate of 2.6%±5.1% (mean ± SD). Multiple regression analysis 
revealed that ECD loss was significantly associated with the cataract grade (P=0.019) and 
preoperative anterior chamber depth (P=0.023).
Conclusion: With modern small incision cataract surgery, the ECD loss varied with surgical 
invasions due to severe cataract and shallow anterior chamber, and the presence of PEX was 
least affected.
Keywords: pseudoexfoliation syndrome, corneal endothelial cell loss, cataract surgery
Introduction
Pseudoexfoliation syndrome (PEX) is a common clinical condition that is character-
ized by the development of white and dandruff-like flakes in the anterior segments and 
is often associated with decreases and morphological changes in corneal endothelial 
cells.1,2 It is known that the presence of PEX aggravates the risk of intraoperative com-
plications during cataract surgery because of poor pupil dilation and fragile zonules.3–6 
However, whether PEX is a risk factor for reduction in corneal endothelial cell density 
(ECD) after cataract surgery is still controversial. One study showed that a reduction 
in ECD was significantly greater in eyes with PEX,7 whereas other studies reported 
contradictory findings.8–10 There are inherent difficulties in comparative assessments 
of ECD between eyes with and without PEX. First, advanced patient age11,12 and the 
presence of PEX1,2 negatively affect ECD regardless of the performance of cataract 
surgery; thus, preoperative matching between the two groups is not easy. Second is 
the accuracy of the ECD assessment; variance in ECD counting is reported to be 6%, 
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even when images of excellent quality are used.13 Furthermore, 
ECD counting may vary by 2%–5% when several examiners 
are involved.11
Because designing a well-controlled comparative study is 
difficult, a factor analytical study of multiple parameters that 
may influence ECD should be considered. To our knowledge, 
such a factor analysis has rarely been reported. Kaljurand 
and Teesalu revealed that ultrasound (US) power and patient 
age were significant factors for ECD reduction.9 Polymethyl 
methacrylate intraocular lenses were implanted through 
enlarged incisions, so that the reductions in ECD were high 
in both groups (18.1% and 11.6% in the PEX and control 
groups, respectively). Hence, the results cannot be applied 
to the current small incision cataract surgery. The purpose 
of this study was to investigate the factors associated with 
reduction in ECD when eyes with PEX underwent modern 
small incision cataract surgery.
Methods
This retrospective study was performed in accordance with 
the Declaration of Helsinki, and the study protocol was 
approved by the ethics review board of Miyata Eye Hospital. 
Written informed consent for use of the clinical data was 
obtained from all patients. The clinical records of patients 
who had eyes with PEX and who had undergone cataract 
surgery from June 2010 to May 2013 were reviewed. The 
inclusion criteria were an eye with PEX that was diagnosed 
preoperatively under slit lamp microscopy and an eye that 
had undergone cataract surgery with phacoemulsification and 
aspiration and intraocular lens implantation into the capsular 
bag. In cases of bilateral cataract surgery, the first eye was 
included for analysis. Eyes with corneal pathologies, uveitis, 
history of other intraocular surgery, laser iridotomy, com-
bined surgery with trabeculectomy or vitrectomy, conver-
sion to extracapsular cataract extraction, intraocular surgery 
during postoperative observation duration, and patients who 
were younger than 60 years were excluded.
Before cataract surgery, ECD, anterior chamber depth (ACD), 
and dilated pupil diameter were examined. ECD in the center of 
the cornea was measured using a specular microscope (FA-3509; 
KONAN MEDICAL, Nishinomiya, Hyogo, Japan), and expe-
rienced examiners selected the reference cells for counting the 
ECD with the installed software. ACD was measured using the 
ultrasonic A-scan pachymetry. The severity of the cataract was 
graded using the Emery-Little classification. The concomitance 
of diabetes mellitus and glaucoma was also recorded.
All cataract surgeries were performed by experienced 
surgeons using an INFINITI Vision System (Alcon 
Laboratories, Inc., Fort Worth, TX, USA). After creating a 
superior scleral incision of 2.2–2.4 mm in width, the cataract 
was removed with phacoemulsification and aspiration, while 
the corneal endothelial cells were protected using the soft-
shell technique.14 When pupillary dilation was insufficient, 
the pupil was enlarged by multiple partial sphincterotomies 
or the use of iris expanders. In cases of zonular dialysis, 
a capsular tension ring was used. Surgery time and the time 
(US time) and total power (US total power) of the ultrasonic 
that was applied were recorded.
The ECD was measured 3 months after surgery, and the 
reduction rate in ECD was calculated. The aqueous flare intensity 
was measured using a laser flare meter (FM-500; Kowa, Nagoya, 
Aichi, Japan) at 1 week and 1 month postoperatively.
Factors related to the reduction rate in ECD were 
evaluated by using multiple regression analysis. First, the 
cross-correlation and principal factor analyses were con-
ducted for excluding the parameters that would have led 
to multicollinearity with other parameters. Then, step-wise 
multiple regression analysis with respect to the reduction 
rate in ECD was performed with the selected parameters. 
The results are expressed as the mean ± SD for continuous 
variables and as frequencies and percentages for categorical 
variables. A P-value of ,0.05 was considered as statisti-
cally significant.
Results
Seventy-eight eyes of 78 patients (23 men and 55 women) were 
enrolled. The mean age of the patients was 78.2±6.8 years 
(range 63–93 years). Surgery was performed by seven 
experienced surgeons. Table 1 shows the preoperative, 
intraoperative, and postoperative demographic data. Preop-
eratively, the ECD was 2,464±337 cells/mm2, and 3 months 
postoperatively, the ECD was 2,400±347 cells/mm2, giving 
a reduction rate of ECD of 2.6%±5.1% ranging from −6.4% 
to 18.4%. With the sample size and a significance level of 
5%, the detection power in multiple regression analysis of the 
two factors was anticipated to be 75% when R2 was 0.10.
The parameters used in the multiple regression analysis 
resulted in patient age, preoperative ECD, dilated pupil 
diameter, cataract grade, concomitance of diabetes mellitus or 
glaucoma, preoperative ACD, surgery time, US time, US total 
power, pupillary enlargement, and aqueous flare intensity at 
1 week and 1 month postoperatively. The analysis yielded 
a significant multiple correlation (R2=0.12, P=0.006), and 
the final linear regression model included significant para-
meters of the cataract grade (P=0.019) and preoperative ACD 
(P=0.023) (Table 2). The ECD was reduced by 1.39% with 
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a step of the Emery-Little classification and by 3.45% with 
a 1 mm decrease in the preoperative ACD. Figures 1 and 2 
show the relationships between the reduction rate in ECD 
and cataract grade (the Emery-Little classification) as well 
as the preoperative ACD.
Discussion
In the current study, the reduction rate in ECD was 
2.6%±5.1%. In previous studies, the reduction rate in ECD 
due to cataract surgery in PEX eyes was reported to be 9.0% 
at 3 months postoperation,7 11.1% at 6 months postoperation,8 
and 18.1% at 1 month postoperation.9 The difference from 
the current study might be because of differences in the 
preoperative ECD, patient ages, and surgical procedure. The 
current study used a small incision, the soft-shell technique, 
and surgical instruments equipped with sophisticated intra-
operative fluidics.
The current study showed a significant association of the 
cataract grade. In eyes without PEX, a higher density cataract 
needs more US time and US total power,15,16 resulting in a 
significant increase in the risk of ECD reduction.10,15,17,18 The 
previous comparison between PE and control eyes showed 
no significant differences in the cataract grade and the reduc-
tion in ECD.19 Thus, the reduction in ECD resulting from the 
cataract grade was not considered to be PEX related.
The other parameter that significantly affected the reduc-
tion in ECD was preoperative ACD. A shallower anterior 
chamber reduced ECD more after cataract surgery. An in vitro 
investigation shows that corneal endothelial cell damage 
decreased with the distance to the phacoemulsification tip.20 
In eyes without PEX, a population-based study revealed that 
eyes with shallower ACDs had an anatomically shorter ocular 
axial length21 and that a short ocular axial length was a risk for 
Table 1 Perioperative parameters in eyes with pseudoexfoliation 
syndrome
Parameter Mean ± SD (range)
Preoperative
aCD (mm) 3.06±0.37 (2.17–4.08)
eCD (cells/mm2) 2,464±337 (1,374–3,165)
Dilated pupil diameter (mm) 5.72±0.95 (3.0–8.0)
Cataract grade (emery-little) 1.64±0.97 (grade 1: 48 eyes; grade 2: 
16 eyes; grade 3: nine eyes; grade 4:  
four eyes; and grade 5: one eye)
Diabetes mellitus/glaucoma  
(eyes)
13/17
intraoperative
surgery time (minutes) 14.6±5.7 (6.0–30.3)
Us time (seconds) 88.6±30.9 (37–177)
Us total power (%minutes) 26.7±12.7 (5.9–76.1)
Pupillary enlargement  
manipulation (eyes)
24 (expander: 17 and  
sphincterotomies: 7)
Postoperative
eCD (cells/mm2) 2,400±347 (1,332–3,226)
Aqueous flare intensity
1 week 13.4±7.3 (4.2–38.1)
1 month 13.5±7.2 (3.9–41.3)
Abbreviations: aCD, anterior chamber depth; eCD, endothelial cell density; Us, 
ultrasound; sD, standard deviation.
Table 2 results of multivariable regression analysis to show the 
parameters significantly associated with ECD loss
Parameter Regression  
coefficient
95% CI P-value
Cataract grade 1.39 0.24–2.55 0.019
Preoperative aCD −3.45 −6.40 to −0.49 0.023
Concomitance of  
diabetes mellitus
−3.00 −5.97 to 0.01 0.051
Constant 1.87–20.77 0.020
Abbreviations: aCD, anterior chamber depth; eCD, endothelial cell density; Ci, 
confidence interval.
Figure 1 relationship between the eCD reduction rate and cataract grade.
Notes: The reduction rate was significantly associated with the cataract grade (the 
Emery-Little classification). Solid line denotes a regression equation obtained by 
multiple regression analysis (R2=0.12, P=0.006).
Abbreviation: eCD, endothelial cell density.
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Figure 2 relationship between the rate of eCD loss and preoperative aCD.
Note: The rate of ECD loss was significantly associated with preoperative ACD 
(the multiple step-wise regression analysis).
Abbreviations: aCD, anterior chamber depth; eCD, endothelial cell density.
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ECD reduction after cataract surgery.18,22 Comparison of the 
ACD between eyes with and without PEX is still unknown; 
Arnarsson et al23 reported no difference, while Zheng et al24 
found significantly shallower ACD in eyes with PEX. To date, 
concluding that preoperative ACD was related with PEX is 
difficult. Further investigations will be necessary.
The intraoperative pupillary size is significantly smaller 
in eyes with PEX.4,7,25 Insufficient mydriasis is a risk of 
intraoperative complications, such as posterior capsule rup-
ture and vitreous loss.26 The current study applied pupillary 
enlargement for cases of poor pupillary dilatation. Although 
the pupillary enlargement increased surgery time, there was 
no significant reduction in ECD, suggesting that pupillary 
enlargement to secure a sufficient working space during pha-
coemulsification was effective and safe in eyes with PEX.
There are limitations in the current study. First, the 
severity of PEX was not assessed. Zimmermann et al27 clas-
sified eyes into two grades based on the amount of visible 
PEX deposits on the crystalline lens, and eyes with a more 
severe PEX grade compromised ECD, and showed that ECD 
decreased with higher PEX grades. In the current study, such 
grading was not available. Second, the retrospective study 
examined the ECD only, and a morphological analysis of 
corneal endothelial cells was not performed. After cataract 
surgery in eyes with PEX, the sizes of the corneal endothelial 
cells were increased and the cell shape became more variable.7 
Morphological analyses, such as of the rate of the hexagonal 
cells and variation in cell size, might be more sensitive indica-
tors. Third, there was no control group in the current study. 
Comparative assessments of ECD inherently pose difficulties 
in matching preoperative demographics and accuracy of the 
ECD assessment, whereas the comparison of reduction in 
ECD and patient’s demographics demonstrates no significant 
difference,19 which supported the analysis results in the current 
study. Hence, we concluded that the current analysis with no 
control group would be effective.
Conclusion
The current study indicated that a higher cataract grade and 
shallower preoperative anterior chamber are risk factors for 
ECD reduction after cataract surgery in eyes with PEX. These 
two factors are not unique to PEX, and there has been no 
known difference in such parameters between eyes with and 
without PEX. Thus, it is suggested that corneal endothelial 
cell damage in eyes with PEX is attributable to surgical inva-
sion itself and it is not clear at present whether the presence 
of PEX further added to an ECD reduction.
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